Showing 661-670 of 6902 results for "".
Advances in Treatment of Hypoparathyroidism: Importance of Genetic Testing for Autosomal Dominant Hypocalcemia Type 1
https://reachmd.com/programs/cme/advances-in-treatment-of-hypoparathyroidism-importance-of-genetic-testing-for-autosomal-dominant-hypocalcemia-type-1/36097/Tune in to explore ADH type 1 care! Learn to recognize clinical features, enhance your diagnosis with genetic testing, and assess emerging therapies.MS Minute: Update on BTK Inhibitors for Multiple Sclerosis—A New Treatment That Brings New Hope
https://reachmd.com/diseases-diagnoses/ms-immune-disorders/update-on-btk-inhibitors-for-multiple-sclerosis-a-new-treatment-that-brings-new-hope/40007/BTK inhibitors are the first class of medications to slow disability progression in secondary progressive multiple sclerosis without clinical relapses.Long-Term PNH Management: Addressing Treatment Goals Beyond Symptom Control
https://reachmd.com/programs/medical-industry-feature/long-term-pnh-management-treatment-goals/35652/Patients with paroxysmal nocturnal hemoglobinuria (PNH) require lifelong therapy.1,2 Long-term data on an available treatment option can help address patient goals—not only in treating symptoms, but also long-term complications. Hear from Arati Chand, MD and Bhumika Patel, MD as they review two-yearUtilization and Management of Antibody-Drug Conjugates in Metastatic Breast Cancer: The Relationship Between ADCs and HER2
https://reachmd.com/programs/cme/utilization-and-management-of-antibody-drug-conjugates-in-metastatic-breast-cancer-the-relationship-between-adcs-and-her2/14552/Are antibody-drug conjugates right for your patients with HER2 mBC? Our experts are breaking down the latest data, and they may surprise you.Confronting Antisemitism in Medicine and Dermatology
https://reachmd.com/ma-issues-index/march-april-2026-issue/confronting-antisemitism-in-medicine-and-dermatology/56632/Why rising hate demands action from physicians and practice leadersCombination Therapy Slows Myopia Progression in Children with Premyopia
https://reachmd.com/programs/eye-on-ocular-health/combination-therapy-slows-myopia-progression-in-children-with-premyopia/36447/On the Frontline: Empowering IO Therapies for Patients with HER2-Negative G/GEJC
https://reachmd.com/programs/project-oncology/io-therapies-for-patients-with-her2-negative-ggejc/35513/For patients who are diagnosed with metastatic gastric cancer, the five-year overall survival rate is roughly seven percent, underscoring the need for additional treatment options.1 Fortunately, there has been advancement in gastric cancer care, including the FDA approval of tislelizumab plus platinPrejuvenation with Monopolar Radiofrequency Treatment
https://reachmd.com/ma-issues-index/march-april-2026-issue/prejuvenation-with-monopolar-radiofrequency-treatment/56633/The science behind collagen banking in prejuvenationAddressing Barriers to MenB and MenACWY Vaccination
https://reachmd.com/programs/vaccination/addressing-barriers-to-menb-and-menacwy-vaccination/37107/CDC - Global Tobacco Control: A Prevention "Best Buy," Part 1
https://reachmd.com/programs/grand-rounds-nation/cdc-global-tobacco-control-a-prevention-best-buy-part-1/6602/This session of CDC′s Public Health Grand Rounds explores the control of tobacco use-the leading preventable cause of premature death and disease worldwide. Currently, approximately 6 million people die each year due to tobacco-related illnesses, a figure expected to increase to more than 8 million